These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38872492)

  • 21. Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?
    Dohrn MF; Othman A; Hirshman SK; Bode H; Alecu I; Fähndrich E; Karges W; Weis J; Schulz JB; Hornemann T; Claeys KG
    Eur J Neurol; 2015 May; 22(5):806-14, e55. PubMed ID: 25623782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 study.
    Ziegler D; Thorand B; Strom A; Bönhof GJ; Knebel B; Schleicher E; Rathmann W; Herder C; Maalmi H; Gieger C; Heier M; Meisinger C; Roden M; Peters A; Grallert H
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3834. PubMed ID: 38961642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus.
    Chang KH; Chen CM; Lin CN; Tsai SS; Lyu RK; Chu CC; Ro LS; Liao MF; Chang HS; Weng YC; Hwang JS; Kuo HC
    J Peripher Nerv Syst; 2023 Dec; 28(4):651-663. PubMed ID: 37831393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of persistent organic pollutants with sensorimotor neuropathy in participants with and without diabetes or prediabetes: Results from the population-based KORA FF4 study.
    Schwarz M; Wolf K; Schneider A; Schramm KW; Bongaerts B; Henkelmann B; Herder C; Roden M; Peters A; Ziegler D; Rathmann W
    Int J Hyg Environ Health; 2021 Jun; 235():113752. PubMed ID: 34020228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic value of longitudinal HbA1c variability in predicting the development of diabetic sensorimotor polyneuropathy among patients with type 2 diabetes mellitus: A prospective cohort observational study.
    Lai YR; Chiu WC; Huang CC; Cheng BC; Yu IH; Kung CT; Lin TY; Chiang HC; Kuo CA; Lu CH
    J Diabetes Investig; 2024 Mar; 15(3):326-335. PubMed ID: 38168098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study.
    Herder C; Kannenberg JM; Niersmann C; Huth C; Carstensen-Kirberg M; Wittenbecher C; Schulze M; Blüher M; Rathmann W; Peters A; Roden M; Meisinger C; Thorand B
    Eur J Endocrinol; 2017 Oct; 177(4):277-286. PubMed ID: 28679518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy.
    Herder C; Bongaerts BW; Ouwens DM; Rathmann W; Heier M; Carstensen-Kirberg M; Koenig W; Thorand B; Roden M; Meisinger C; Ziegler D;
    Diabet Med; 2015 Nov; 32(11):1479-83. PubMed ID: 26094489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening tests for distal symmetrical polyneuropathy in Latin American patients with type 2 diabetes mellitus.
    Gómez-Banoy N; Cuevas V; Soler F; Pineda MF; Mockus I
    Arch Endocrinol Metab; 2017; 61(5):470-475. PubMed ID: 28724059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study).
    Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A
    Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy.
    Dyck PJ; O'Brien PC; Litchy WJ; Harper CM; Klein CJ; Dyck PJ
    Diabetes Care; 2005 Sep; 28(9):2192-200. PubMed ID: 16123489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between distal sensorimotor polyneuropathy and cardiovascular complications in diabetic patients in the North-Eastern region of Hungary.
    Pető A; Tóth LI; Hernyák M; Lőrincz H; Molnár Á; Nagy AC; Lukács M; Kempler P; Paragh G; Harangi M; Ferenc S
    PLoS One; 2024; 19(7):e0306482. PubMed ID: 38959204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postchallenge hyperglycemia is positively associated with diabetic polyneuropathy: the KORA F4 study.
    Bongaerts BW; Rathmann W; Kowall B; Herder C; Stöckl D; Meisinger C; Ziegler D
    Diabetes Care; 2012 Sep; 35(9):1891-3. PubMed ID: 22751964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes.
    Schamarek I; Herder C; Nowotny B; Carstensen-Kirberg M; Straßburger K; Nowotny P; Strom A; Püttgen S; Müssig K; Szendroedi J; Roden M; Ziegler D;
    Eur J Endocrinol; 2016 Apr; 174(4):433-43. PubMed ID: 26733478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of cardiac stress biomarkers with incident type 2 diabetes and changes in glucose metabolism: KORA F4/FF4 study.
    Sujana C; Seissler J; Jordan J; Rathmann W; Koenig W; Roden M; Mansmann U; Herder C; Peters A; Thorand B; Then C
    Cardiovasc Diabetol; 2020 Oct; 19(1):178. PubMed ID: 33066780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study.
    Raputova J; Srotova I; Vlckova E; Sommer C; Üçeyler N; Birklein F; Rittner HL; Rebhorn C; Adamova B; Kovalova I; Kralickova Nekvapilova E; Forer L; Belobradkova J; Olsovsky J; Weber P; Dusek L; Jarkovsky J; Bednarik J
    Pain; 2017 Dec; 158(12):2340-2353. PubMed ID: 28858986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations.
    Haque F; Ibne Reaz MB; Chowdhury MEH; Md Ali SH; Ashrif A Bakar A; Rahman T; Kobashi S; Dhawale CA; Sobhan Bhuiyan MA
    Comput Biol Med; 2021 Dec; 139():104954. PubMed ID: 34715551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
    Xu J; Cai M; Wang Z; Chen Q; Han X; Tian J; Jin S; Yan Z; Li Y; Lu B; Lu H
    J Endocrinol Invest; 2023 May; 46(5):869-882. PubMed ID: 36282471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review.
    Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P
    Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist.
    Pafili K; Trypsianis G; Papazoglou D; Maltezos E; Papanas N
    Curr Vasc Pharmacol; 2020; 18(1):50-56. PubMed ID: 30156161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sensory Phenotypes Provide Insight Into the Natural Course of Diabetic Polyneuropathy.
    Tsilingiris D; Schimpfle L; von Rauchhaupt E; Sulaj A; Seebauer L; Herzig S; Szendroedi J; Kopf S; Κender Ζ
    Diabetes; 2024 Jan; 73(1):135-146. PubMed ID: 37862374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.